FDA approves first home brain device for depression
NEWNow you can listen to News articles!
For the first time, Americans with depression will soon be able to use a prescription brain stimulation device at home.
The approval comes from the U.S. Food and Drug Administration and marks a major shift in the way mental health conditions can be treated. The newly approved device is called FL-100 and comes from Flow Neuroscience.
It is designed for adults 18 years and older with moderate to severe major depressive disorder. Doctors may prescribe it as a stand-alone treatment or along with antidepressants and therapy. This decision is important because depression affects more than 20 million adults in the U.S. About one-third do not get enough relief from medications or stop taking them because of side effects.
Sign up to receive my FREE CyberGuy report
Get my best tech tips, urgent security alerts, and exclusive offers delivered straight to your inbox. Plus, you’ll get instant access to my Ultimate Guide to Surviving Scams, free when you join me CYBERGUY.COM information sheet.
A SIMPLE DAILY HABIT MAY HELP RELIEVE DEPRESSION MORE THAN MEDICATIONS, RESEARCHERS SAY

Flow Neuroscience has obtained approval from the US Food and Drug Administration for its FL-100 prescription brain stimulation device. (Flow neuroscience)
How the Flow FL-100 works
The FL-100 uses transcranial direct current stimulation, often abbreviated as tDCS. This technology sends a gentle electrical current to the prefrontal cortex, a brain region linked to mood regulation and stress response. In many people with depression, activity in this area is reduced. By stimulating it, the device aims to restore healthier brain signaling over time. The system looks like a lightweight headset and pairs with a mobile app. Patients use it at home for about 30 minutes a day while doctors monitor progress remotely.
The clinical results behind the approval.
The FDA based its decision on a randomized controlled trial that evaluated home use under remote supervision. Participants who received active stimulation showed significant improvement on self-reported and clinician-rated depression scales. After 10 weeks of treatment, patients experienced an average symptom improvement of 58% compared to the control group. Many users reported noticeable changes within the first three weeks. The study was published in the journal Nature Medicine, adding credibility to the findings. Side effects were generally mild and short-lived. Reported problems included skin irritation, redness, headaches, and brief stinging sensations at the electrode sites.

The FDA approved the first prescription brain stimulation device for home treatment of depression in the US, marking a major shift in mental health care. (photo by ISSAM AHMED/News via Getty Images)
A growing shift toward technology-enabled mental health care
Flow’s device has already been used by more than 55,000 people across Europe, the UK, Switzerland and Hong Kong. In the UK, it is prescribed in parts of the public health system. Company leaders say the U.S. approval opens the door to broader access to non-drug treatment options. The impulse is not isolated. In 2025, researchers at UCLA Health developed another experimental brain stimulation approach, indicating rapid growth in this field. Taken together, these advances suggest that home neuromodulation could soon become a standard part of depression treatment rather than a marginal option.
When will the device be available?
Flow expects the FL-100 to be available to U.S. patients in the second quarter of 2026. A prescription will be required and the companion app will be available on iOS and Android. The company also plans to explore additional uses for its platform, including sleep disorders, addiction and traumatic brain injuries.
10 HEALTHTECH PRODUCTS THAT STEAL THE SPOTLIGHT AT CES 2026

Flow Neuroscience’s FL-100 headphones provide gentle electrical stimulation to the brain and can be prescribed for home use under medical supervision. (Flow neuroscience)
What to know before trying Flow
Flow is approved by the FDA for adults 18 years and older with moderate to severe major depressive disorder and requires a prescription from a licensed healthcare provider. Doctors may recommend it alone or along with medications or therapy. The headset is non-invasive and intended for home use, but is not intended for emergency situations or people considered resistant to treatment. It is also not a substitute for crisis care or immediate mental health support. Most users wear the headphones for about 30 minutes per session. Slight tingling, warmth, skin irritation, or headaches may occur, especially at first. These effects are usually short-lived and are monitored by a doctor through the companion app.
Flow is combined with a mobile app that guides treatment and supports remote clinical monitoring. Your provider sets the treatment plan and the device follows prescribed settings to ensure safe use. Pricing and insurance coverage may vary once the device is available in the U.S. Some patients may access Flow through clinics, research programs, or as it becomes more widely adopted into routine depression care. The conclusion is simple. Flow adds another evidence-based option, which is not a cure or a one-size-fits-all solution. For people who have struggled to find relief, having another clinically proven option can be very important.
What does this mean to you?
If you or a loved one struggles with depression, this approval expands the range of real treatment options. It offers a drug-free route that can be used at home under medical guidance. For patients who have not responded well to medication or are experiencing unwanted side effects, this could provide another way forward. It also reflects a broader trend toward personalized, technology-enabled mental health care.
Take my quiz: How safe is your online security?
Do you think your devices and data are really protected? Take this quick quiz to see where you stand digitally. From passwords to Wi-Fi settings, you’ll get a personalized breakdown of what you’re doing well and what you need to improve. Take my quiz here: Cyberguy.com.
ELON MUSK SHARES PLAN TO MASS PRODUCE BRAIN IMPLANTS FOR PARALYSIS AND NEUROLOGICAL DISEASES

The newly approved device is aimed at adults with moderate to severe depression and can be used in conjunction with medication or therapy. (Photo by Sarah Silbiger/Getty Images)
Kurt’s Key Takeaways
This FDA approval seems like a real turning point. For years, brain stimulation for depression remained confined to clinics. Now it can happen at home with a doctor still guiding the process. That’s important for people who have tried medications, faced side effects, or felt stuck with limited options. This device won’t be the right answer for everyone, but it gives patients and doctors a more proven tool to work with. And for many people living with depression, having another option could make all the difference.
If a doctor could prescribe brain stimulation headphones instead of another pill, would you be willing to try it? Let us know by writing to us at Cyberguy.com.
CLICK HERE TO DOWNLOAD THE News APP
Sign up to receive my FREE CyberGuy report
Get my best tech tips, urgent security alerts, and exclusive offers delivered straight to your inbox. Plus, you’ll get instant access to my Ultimate Guide to Surviving Scams, free when you join me CYBERGUY.COM information sheet.
Copyright 2026 CyberGuy.com. All rights reserved.
Kurt “CyberGuy” Knutsson is an award-winning technology journalist with a deep love for technology, gear and gadgets that improve lives with his contributions to News and News Business since mornings on “News & Friends.” Do you have any technical questions? Get Kurt’s free CyberGuy newsletter, share your voice, a story idea or comment on CyberGuy.com.


